Hospital de la Santa Creu i Sant PauBarcelona, Catalonia, Spain
Paper 45 - LONG-TERM EFFICACY AND SAFETY OF VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT): RESULTS FROM THE MOTION PHASE 3 TRIAL
Friday, November 14, 20252:30 PM - 3:30 PM EST
Disclosure information not submitted.